Literature DB >> 28861671

Intensive care medicine in 2050: vasopressors in sepsis.

Jean-Louis Teboul1, Jacques Duranteau2, James A Russell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28861671     DOI： 10.1007/s00134-017-4909-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

1.  Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.

Authors:  Roeland F Stolk; Tom van der Poll; Derek C Angus; Johannes G van der Hoeven; Peter Pickkers; Matthijs Kox
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

2.  Predicting vasopressor needs using dynamic parameters.

Authors:  M Ignacio Monge García; Michael R Pinsky; Maurizio Cecconi
Journal:  Intensive Care Med       Date:  2017-03-08       Impact factor: 17.440

3.  High versus low blood-pressure target in patients with septic shock.

Authors:  Pierre Asfar; Ferhat Meziani; Jean-François Hamel; Fabien Grelon; Bruno Megarbane; Nadia Anguel; Jean-Paul Mira; Pierre-François Dequin; Soizic Gergaud; Nicolas Weiss; François Legay; Yves Le Tulzo; Marie Conrad; René Robert; Frédéric Gonzalez; Christophe Guitton; Fabienne Tamion; Jean-Marie Tonnelier; Pierre Guezennec; Thierry Van Der Linden; Antoine Vieillard-Baron; Eric Mariotte; Gaël Pradel; Olivier Lesieur; Jean-Damien Ricard; Fabien Hervé; Damien du Cheyron; Claude Guerin; Alain Mercat; Jean-Louis Teboul; Peter Radermacher
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

4.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Authors:  Anthony C Gordon; Alexina J Mason; Neeraja Thirunavukkarasu; Gavin D Perkins; Maurizio Cecconi; Magda Cepkova; David G Pogson; Hollmann D Aya; Aisha Anjum; Gregory J Frazier; Shalini Santhakumaran; Deborah Ashby; Stephen J Brett
Journal:  JAMA       Date:  2016-08-02       Impact factor: 56.272

5.  Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock.

Authors:  Bettina Temmesfeld-Wollbrück; Bernhard Brell; István Dávid; Martin Dorenberg; Jörn Adolphs; Bernd Schmeck; Norbert Suttorp; Stefan Hippenstiel
Journal:  Intensive Care Med       Date:  2007-02-22       Impact factor: 17.440

6.  Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock.

Authors:  Micah R Whitson; Edwin Mo; Tasnima Nabi; Lauren Healy; Seth Koenig; Mangala Narasimhan; Paul H Mayo
Journal:  Chest       Date:  2016-03-04       Impact factor: 9.410

7.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 8.  Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.

Authors:  Ary Serpa Neto; Antônio P Nassar; Sérgio O Cardoso; José A Manetta; Victor G M Pereira; Daniel C Espósito; Maria C T Damasceno; James A Russell
Journal:  Crit Care       Date:  2012-08-14       Impact factor: 9.097

9.  A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.

Authors:  Xinrong He; Fuhong Su; Fabio Silvio Taccone; Régent Laporte; Anne Louise Kjølbye; Jing Zhang; Keliang Xie; Mouhamed Djahoum Moussa; Torsten Michael Reinheimer; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

10.  Genomics and pharmacogenomics of sepsis: so close and yet so far.

Authors:  James A Russell
Journal:  Crit Care       Date:  2016-07-07       Impact factor: 9.097
View more
  4 in total

1.  Focus on blood pressure targets and vasopressors in critically ill patients.

Authors:  Anders Perner; Peter B Hjortrup; Yaseen Arabi
Journal:  Intensive Care Med       Date:  2019-08-05       Impact factor: 17.440

2.  Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review.

Authors:  Mathieu Jozwiak; Guillaume Geri; Driss Laghlam; Kevin Boussion; Charles Dolladille; Lee S Nguyen
Journal:  Front Med (Lausanne)       Date:  2022-05-23

Review 3.  Vasopressors in septic shock: which, when, and how much?

Authors:  Rui Shi; Olfa Hamzaoui; Nello De Vita; Xavier Monnet; Jean-Louis Teboul
Journal:  Ann Transl Med       Date:  2020-06

4.  Current use of vasopressors in septic shock.

Authors:  Thomas W L Scheeren; Jan Bakker; Daniel De Backer; Djillali Annane; Pierre Asfar; E Christiaan Boerma; Maurizio Cecconi; Arnaldo Dubin; Martin W Dünser; Jacques Duranteau; Anthony C Gordon; Olfa Hamzaoui; Glenn Hernández; Marc Leone; Bruno Levy; Claude Martin; Alexandre Mebazaa; Xavier Monnet; Andrea Morelli; Didier Payen; Rupert Pearse; Michael R Pinsky; Peter Radermacher; Daniel Reuter; Bernd Saugel; Yasser Sakr; Mervyn Singer; Pierre Squara; Antoine Vieillard-Baron; Philippe Vignon; Simon T Vistisen; Iwan C C van der Horst; Jean-Louis Vincent; Jean-Louis Teboul
Journal:  Ann Intensive Care       Date:  2019-01-30       Impact factor: 6.925
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.